Correlation Between SynCore Biotechnology and Alpha Networks

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SynCore Biotechnology and Alpha Networks at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SynCore Biotechnology and Alpha Networks into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SynCore Biotechnology Co and Alpha Networks, you can compare the effects of market volatilities on SynCore Biotechnology and Alpha Networks and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SynCore Biotechnology with a short position of Alpha Networks. Check out your portfolio center. Please also check ongoing floating volatility patterns of SynCore Biotechnology and Alpha Networks.

Diversification Opportunities for SynCore Biotechnology and Alpha Networks

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between SynCore and Alpha is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding SynCore Biotechnology Co and Alpha Networks in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alpha Networks and SynCore Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SynCore Biotechnology Co are associated (or correlated) with Alpha Networks. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alpha Networks has no effect on the direction of SynCore Biotechnology i.e., SynCore Biotechnology and Alpha Networks go up and down completely randomly.

Pair Corralation between SynCore Biotechnology and Alpha Networks

Assuming the 90 days trading horizon SynCore Biotechnology Co is expected to under-perform the Alpha Networks. But the stock apears to be less risky and, when comparing its historical volatility, SynCore Biotechnology Co is 1.55 times less risky than Alpha Networks. The stock trades about -0.07 of its potential returns per unit of risk. The Alpha Networks is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  3,485  in Alpha Networks on August 30, 2024 and sell it today you would earn a total of  320.00  from holding Alpha Networks or generate 9.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

SynCore Biotechnology Co  vs.  Alpha Networks

 Performance 
       Timeline  
SynCore Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SynCore Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Alpha Networks 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Alpha Networks are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Alpha Networks may actually be approaching a critical reversion point that can send shares even higher in December 2024.

SynCore Biotechnology and Alpha Networks Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SynCore Biotechnology and Alpha Networks

The main advantage of trading using opposite SynCore Biotechnology and Alpha Networks positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SynCore Biotechnology position performs unexpectedly, Alpha Networks can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alpha Networks will offset losses from the drop in Alpha Networks' long position.
The idea behind SynCore Biotechnology Co and Alpha Networks pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities